Video

Focusing on Improving Depression in HNC Survivors

As cancer survivors are living longer thanks to new treatments, it is essential that health care providers and researchers put more focus on depression.

Now that patients with head and neck cancer (HNC) — as well as many other cancer types – are living much longer, it is essential that researchers and health care professionals recognize the importance of depression and quality-of-life issues, according to Nosayaba Osazuwa-Peters, BDS, MPH, CHES, Instructor, Department of Otolaryngology-Head and Neck Surgery, Saint Louis University School of Medicine.

Osazuwa-Peters’ recent research shed light on suicide rates in HNC survivors, which he noted were on the rise for all cancer types. Many suicide risk factors, such as depression and pain, are common in survivors, so it is imperative that signs of suicide are recognized in this population so individuals can get the help that they may need.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Related Content